NCT05421299View on ClinicalTrials.gov

A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate

CompletedOBSERVATIONAL
Enrollment

378

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Stem Cell Transplantation
Trial Locations (1)

08540

Local Institution, Princeton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05421299 - A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Abatacept in Combination With a Calcineurin Inhibitor and Methotrexate | Biotech Hunter | Biotech Hunter